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We investigated whether tobacco use causes cutaneous squamous cell carcinoma (CSCC) in a large cohort study with complete and
long-term follow-up. A total of 756 incident cases occurred in a cohort of 337311 men during a 30-year follow-up period, but no
association was found between any kind of smoking tobacco use and CSCC risk, nor any risk change with increasing dose, duration or
time since smoking cessation. Snuff use was associated with a decreased risk of CSCC. Overall, our study provides no evidence that
tobacco use increases the risk of CSCC.
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Cutaneous squamous cell carcinoma (CSCC) is a relatively
common cancer worldwide, more common in males and the
elderly, and a four-fold increase in age-standardised incidence has
occurred in Sweden over the last four decades and this trend seems
to be continuing (Cancer Incidence in Sweden, 2003). Ultraviolet
(UV) radiation is recognised as the most important risk factor for
CSCC (Armstrong and Kricker, 2001), although other definite or
possible risk factors include immunosuppression (London et al,
1995), infection with oncogenic viruses (Harwood et al, 2000),
chronic inflammatory skin diseases (Boffetta et al, 2001), exposure
to arsenic and high body mass index (BMI) (Chen et al 2003).
Tobacco smoke and oral snuff contain a large number of
carcinogenic substances (Wiencke, 2002; IARC, 2004). However,
the relationship between tobacco use and/or oral snuff and CSCC
has not been sufficiently investigated among humans and the
evidence has been somewhat conflicting (Grodstein et al, 1995;
Nilsson, 1998; Ramsay et al, 2000; de Hertog et al, 2001; Chen et al,
2003; Lindelo ¨f et al, 2003; Struijk et al, 2003; IARC, 2004).
We have investigated the possible role of tobacco smoking, snuff
dipping and BMI in CSCC aetiology in a large nationwide cohort of
Swedish construction workers.
SUBJECTS AND METHODS
The cohort and follow-up
The Construction Industry’s Organization for Working Environ-
ment, Safety and Health (Byggha ¨lsan) provided outpatient health
services to construction workers all over Sweden from 1969
through 1993. Beginning in 1971, the information collected was
stored in a computerised register, as described elsewhere (Nyre ´n
et al, 1996). The first visit to the clinic defined entry into the
cohort. Since no information on smoking history was collected
from 1975 to 1977, we only included the workers who were
registered between 1971–1975 and 1978–1992. Since over 95% of
the cohort were men, we restricted our study to male workers and
overall, 337311 men were included in the subsequent analyses.
Exposure information was obtained by self-administered ques-
tionnaires double-checked by a nurse. The quality of the tobacco
data has been reviewed and the answers are believed to be of high
validity.
Each cohort member was followed from date of entry into
the cohort until CSCC diagnosis, death, emigration or end of
follow-up 31 December 2000, whichever occurred first. The unique
Swedish 10-digit personal identification number was used for
follow-up by record linkage to the nationwide National Death
Registry (date and cause of death), the Migration Registry (date
of emigration) and the Swedish Cancer Registry (Cancer Incidence
in Sweden, 2003).
Statistical analyses
The distribution of BMI was analysed in four groups according to
the World Health Organization (WHO) criteria: underweight
p18.5; normal weight 18.6–25; overweight 25–30 and obese
430. Age was categorised in 5-year intervals. Cigarettes were
assumed to contain 1g of tobacco and cigars 6g of tobacco each.
Age-adjusted incidence rate ratios (IRR) and 95% confidence
intervals (CI) were estimated using proportional hazards Cox
regression model, with age and the relevant exposure factors as
independent variables (Stata Statistical Software: Release 8.2.
College Station, TX, USA: Stata Corporation). Interaction effects
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model and likelihood ratio tests were used to assess their
significance.
RESULTS
Throughout follow-up, a total of 756 men developed CSCC, the
risk increasing substantially with age. The mean age at entry
was 34.2 (range 14–82) years and cohort members were
followed on average for 19.4 years (range 0–31.3), yielding a
total of 6536910 person-years of follow-up. In total, 58% of the
subjects had ever smoked some tobacco product and 28% were
ever snuff dippers. About 43% used one tobacco product only
(29% were pure cigarette smokers and 13% were pure snuff
dippers) and approximately 21% mixed two or more tobacco
products – most frequently cigarettes and pipe (5%) or cigarettes
and snuff (12%).
Table 1 summarises the IRR and corresponding CI for all
smoking tobacco taken together. Overall, no association between
tobacco and the development of CSCC was found. Former and
current smokers showed an IRR of 0.95 (95% CI 0.77–1.18) and
0.97 (95% CI 0.80–1.17), respectively, compared to those who
never smoked. No effect could be detected with increasing dose,
duration or time since cessation.
Table 2 displays the IRR and CI for the tobacco products
separately and the association with BMI. Again, we found no
effect of any of the different smoking tobacco products on
the risk of developing CSCC. Pure cigarette smokers had an
IRR of 1.04 (95% CI 0.85–1.26), pure cigar smokers 0.88 (95%
CI 0.45–1.71) and pure pipe smokers 0.81 (95% CI 0.62–1.05)
compared to nontobacco users. No dose–response trends were
revealed.
Snuff use was found to be negatively associated with the risk of
developing CSCC (IRR 0.64; 95% CI 0.44–0.95). This effect was
even stronger among those who had used snuff for more than 30
years. Subjects categorised as underweight, overweight or obese
were not at an increased risk of CSCC compared to those of normal
weight.
DISCUSSION
Our main finding is that the use of tobacco smoking is not
associated with an increased risk of CSCC, although we found a
negative association between oral moist snuff and CSCC risk. The
potential impact of occupational sunlight exposure on CSCC in
this cohort has been evaluated previously and no association was
found (Ha ˚kansson et al, 2001), perhaps because outdoor workers
wear protective clothing while working. Unfortunately, we do not
have information on recreational sun habits among the cohort
members.
Previous investigations have reported relative risks of 1.5–4.1
between cigarette smoking and CSCC (Aubry and MacGibbon,
1985; Grodstein et al, 1995; Ramsay et al, 2000; De Hertog et al,
2001; Struijk et al, 2003), whereas others found no such association
(Chen et al, 2003; Lindelo ¨f et al, 2003). In general, most studies
have been case–control in design, focused only on cigarette
smoking and used rather crude exposure measures; previous
cohort studies were unable to study skin cancer since they mainly
used mortality instead of incidence data.
In the few studies of pipe and cigar smoking and BMI as risk
factors of CSCC (De Hertog et al, 2001; Efird et al, 2002; Chen et al,
2003), pipe smoking and underweight have been associated with
elevated risk of CSCC in contrast to our results. No studies have
specifically addressed the impact of snuff use on CSCC.
Table 1 Estimated age-adjusted incidence rate ratios (IRR) and
corresponding 95% confidence intervals (CI) for developing CSCC, by
different dose and duration of tobacco smoking
Exposure variable
No of cases
(%)
Person-years
accumulated IRR (95% CI)
Reference (never tobacco user) 209 (35) 1920810 1 (ref)
Any tobacco smoker
Previous 141 (24) 710190 0.95 (0.77–1.18)
Current 245 (41) 2150910 0.97 (0.80–1.17)
Total smoking tobacco dose
(gday
 1)
p10 222 (39) 1410290 0.99 (0.82–1.19)
11–15 112 (20) 1119380 0.88 (0.70–1.11)
415 27 (5) 230650 0.95 (0.64–1.42)
Years of tobacco smoking
p15 87 (15) 1534570 1.08 (0.83–1.39)
16–25 110 (19) 725130 1.11 (0.87–1.40)
425 188 (32) 563890 0.87 (0.72–1.07)
Time since cessation of
tobacco smoking (years)
a
o10 74 (21) 487210 1.00 (0.76–1.30)
X10 66 (19) 197480 0.89 (0.68–1.18)
aStratified Cox proportional hazards model, by age. CSCC¼cutaneous squamous
cell carcinoma.
Table 2 Estimated age-adjusted incidence rate ratios (IRR) and 95%
confidence intervals (CI) for developing CSCC by different types of
tobacco
Tobacco variable
No. of
cases
a
Person-years
accumulated IRR (95% CI)
Reference (nontobacco users) 209 1920810 1 (ref)
Cigarette smoker 194 1947400 1.04 (0.85–1.26)
b
Cigarettes smoked per day
b,c
o10 105 836590 1.12 (0.88–1.41)
11–20 58 667330 0.92 (0.69–1.24)
420 26 405710 0.90 (0.60–1.36)
Cigar smoker 9 42000 0.88 (0.45–1.71)
b
Pipe smoker 80 358200 0.81 (0.62–1.05)
b
Pipe tobacco (g) smoked per
week
o80 75 338180 0.77 (0.59–1.00)
X80 5 19790 1.12 (0.46–2.73)
Snuff dipper 29 661150 0.64 (0.44–0.95)
b
Years of snuff dipping
o30 14 610320 0.79 (0.46–1.38)
X30 15 44660 0.58 (0.34–0.99)
Mixed user 235 1607340 1.08 (0.90–1.30)
b
BMI
p18.5 3 93390 0.87 (0.28–2.71)
18.6–25 372 4153490 1-ref
26–29 326 1986410 0.95 (0.81–1.10)
430 52 282310 0.98 (0.73–1.32)
aThe discrepancy in number of cases is due to missing information on dose.
bAdjusted
for all other tobacco categories
cStratified Cox proportional hazards model, on age.
BMI¼body mass index; CSCC¼cutaneous squamous cell carcinoma.
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workers are its large size, the prospective collection of exposure
details and almost complete follow-up. Any residual misclassifica-
tion would presumably be nondifferential and would not have any
major impact on the findings.
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